Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Spironolactone might lower the chance of getting rosacea.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

GLP-1RA therapy may increase the risk of hair loss.

Cosmetics can contain harmful chemicals that may cause health issues.

Physical activity, height, and smoking affect prostate cancer risk.

Higher cholesterol levels increase aggressive prostate cancer risk.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Age, stress, and anger increase the risk of hair fall.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Lower SHBG levels may increase the risk of PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Understanding and tracking our body's natural daily rhythms could help improve heart health.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Tailoring COVID-19 measures to risk levels in the military improves health and readiness.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Better nutrition may reduce fecal incontinence in stroke patients by lowering inflammation and improving antioxidant levels.

Obesity and lifestyle strongly affect heart aging.

Balding people may have higher heart disease risk.

CONSORT improves trial reporting but doesn't assess bias.